Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | EYPT | EYEPOINT INC | Healthcare | 215,825.0 | $2.8M | 1.76% | NEW | — | $12.92 | +3.3% |
| 22 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 223,802.0 | $2.6M | 1.67% | NEW | — | $11.83 | +21.6% |
| 23 | — | ZEVRA THERAPEUTICS INC | — | 282,418.0 | $2.6M | 1.66% | +219K | +343.5% | $9.35 | — |
| 24 | — | IMMUNIC INC | — | 2,344,779.0 | $2.6M | 1.65% | NEW | — | $1.12 | — |
| 25 | CHRS | COHERUS ONCOLOGY INC | Healthcare | 1,420,550.0 | $2.4M | 1.52% | NEW | — | $1.70 | -3.5% |
| 26 | OVID | OVID THERAPEUTICS INC | Healthcare | 921,457.0 | $2.0M | 1.28% | NEW | — | $2.21 | +10.8% |
| 27 | — | PALISADE BIO INC | — | 1,115,000.0 | $2.0M | 1.26% | NEW | — | $1.79 | — |
| 28 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 295,771.0 | $1.7M | 1.08% | +254K | +603.3% | $5.82 | -10.5% |
| 29 | QURE | UNIQURE NV | Healthcare | 104,772.0 | $1.7M | 1.08% | NEW | — | $16.35 | +53.8% |
| 30 | LONA | LEONABIO INC | Healthcare | 149,279.0 | $1.5M | 0.94% | — | — | $10.02 | -3.5% |
| 31 | NUVB | NUVATION BIO INC | Healthcare | 329,296.0 | $1.4M | 0.89% | NEW | — | $4.29 | +9.3% |
| 32 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 43,798.0 | $1.3M | 0.82% | NEW | — | $29.85 | -11.7% |
| 33 | EVMN | EVOMMUNE INC | Healthcare | 55,664.0 | $1.3M | 0.81% | NEW | — | $22.99 | +1.6% |
| 34 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 85,791.0 | $1.3M | 0.79% | NEW | — | $14.58 | -12.0% |
| 35 | ALDX | ALDEYRA THERAPEUTICS INC | Healthcare | 730,606.0 | $1.2M | 0.78% | NEW | — | $1.69 | +5.3% |
| 36 | — | ARTIVA BIOTHERAPEUTICS INC | — | 146,369.0 | $950K | 0.60% | NEW | — | $6.49 | — |
| 37 | CNTB | CONNECT BIOPHARMA HLDGS LTD | Healthcare | 209,493.0 | $554K | 0.35% | NEW | — | $2.64 | -9.2% |
| 38 | MSLE | SATELLOS BIOSCIENCE INC | Healthcare | 10,145.0 | $57K | 0.04% | NEW | — | $5.63 | +21.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
75.4%
Energy
24.6%